These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24691174)

  • 1. The evolution of gene transfer, gene therapy, and the RAC: IOM recommendations to the NIH director.
    Federoff HJ; Wagner JE
    Mol Ther; 2014 Apr; 22(4):685-6. PubMed ID: 24691174
    [No Abstract]   [Full Text] [Related]  

  • 2. Future oversight of recombinant DNA research: recommendations of an Institute of Medicine committee.
    Gostin LO; Altevogt BM; Pope AM
    JAMA; 2014 Feb; 311(7):671-2. PubMed ID: 24435443
    [No Abstract]   [Full Text] [Related]  

  • 3. Finding common ground: a summary of the IOM's review of the RAC.
    Dean M
    Mol Ther; 2013 Nov; 21(11):1971-2. PubMed ID: 24201209
    [No Abstract]   [Full Text] [Related]  

  • 4. The evolution of public review and oversight mechanisms in human gene transfer research: joint roles of the FDA and NIH.
    Friedmann T; Noguchi P; Mickelson C
    Curr Opin Biotechnol; 2001 Jun; 12(3):304-7. PubMed ID: 11404110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The National Institutes of Health Oversight of Human Gene Transfer Research: Enhancing Science and Safety.
    O'Reilly M; Jambou R; Rosenthal E; Montgomery M; Hassani M; Gargiulo L; Corrigan-Curay J
    Adv Exp Med Biol; 2015; 871():31-47. PubMed ID: 26374211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moral authority.
    Nature; 2013 Jun; 498(7452):5-6. PubMed ID: 23745195
    [No Abstract]   [Full Text] [Related]  

  • 7. National Institutes of Health Recombinant DNA Advisory Committee (RAC). 91st meeting of the NIH RAC, Bethesda Marriott Hotel, Bethesda, Maryland, June 18-19, 20003.
    National Institutes of Health Recombinant DNA Advisory Committee
    Hum Gene Ther; 2003 Sep; 14(14):1361-5. PubMed ID: 14552317
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotechnology on the RAC--FDA/NIH regulation of human gene therapy.
    Rainsbury JM
    Food Drug Law J; 2000; 55(4):575-600. PubMed ID: 12025851
    [No Abstract]   [Full Text] [Related]  

  • 9. The new RAC: restructuring of the National Institutes of Health recombinant DNA Advisory Committee.
    Beach JE
    Food Drug Law J; 1999; 54(1):49-53. PubMed ID: 11758560
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trial design issues raised during recombinant DNA advisory committee review of gene transfer protocols.
    Scharschmidt T; Lo B
    Hum Gene Ther; 2006 Apr; 17(4):448-54. PubMed ID: 16610932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Workshop on long-term follow-up of participants in human gene transfer research.
    Nyberg K; Carter BJ; Chen T; Dunbar C; Flotte TR; Rose S; Rosenblum D; Simek SL; Wilson C
    Mol Ther; 2004 Dec; 10(6):976-80. PubMed ID: 16156012
    [No Abstract]   [Full Text] [Related]  

  • 12. RAC ponders its purpose: to be or not to be.
    Jenks S
    J Natl Cancer Inst; 1993 Oct; 85(19):1544-6. PubMed ID: 8411224
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant DNA Advisory Committee. Department of Health and Human Services. National Institutes of Health. Minutes of meeting. December 15-16, 1997.
    Hum Gene Ther; 1998 Jul; 9(11):1643-95. PubMed ID: 9694162
    [No Abstract]   [Full Text] [Related]  

  • 14. The RAC: double, double, toil, and trouble?
    Ertl H
    Mol Ther; 2009 Mar; 17(3):397-9. PubMed ID: 19247363
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent developments in gene transfer: risk and ethics.
    Kimmelman J
    BMJ; 2005 Jan; 330(7482):79-82. PubMed ID: 15637370
    [No Abstract]   [Full Text] [Related]  

  • 16. Commentary: Who's afraid of the RAC? Lessons from the oversight of controversial science.
    Kahn JP
    J Law Med Ethics; 2009; 37(4):685-7. PubMed ID: 20122109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAC oversight of gene transfer research: a model worth extending?
    King NM
    J Law Med Ethics; 2002; 30(3):381-9. PubMed ID: 12497698
    [No Abstract]   [Full Text] [Related]  

  • 18. Gene therapy for head and neck cancer.
    Clayman GL
    Head Neck; 1995; 17(6):535-41. PubMed ID: 8847213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NIH/FDA dispute likely to delay research.
    Beardsley T
    Nature; 1985 Aug 15-21; 316(6029):567. PubMed ID: 4033753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NIH Recombinant DNA Advisory Committee data management report. June 18-19, 1998.
    Hum Gene Ther; 1998 Sep; 9(14):2143-61. PubMed ID: 9759940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.